Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Adenosine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.80 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.80 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.80 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.80 |
| ▸ | P2RY1 | P47900 | 7/20 | 0.91 |
| ▸ | P2RX1 | P51575 | 4/20 | 0.91 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.91 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.91 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.91 |
| ▸ | SRC | P12931 | 2/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.91 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.91 |
| ▸ | RNASEL | Q05823 | 4/20 | 0.88 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.84 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.84 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.84 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.84 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.80 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL3498798 | 1.00 | P2RY1 (0.91) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL28358 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL193647 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL3459127 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL19834218 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL28356 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Diphosphate SCHEMBL11579612 | 0.99 | P2RY1 (0.89) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL1496267 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL193645 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL7133726 | 0.99 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539338-A | Disodium adenosine triphosphate trihydrate crystal and preparation method thereof | 苏州赜文医药科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-20250268852-A1 | MICROBIOTA IMPROVING AGENT | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4494696-A1 | MICROBIOTA IMPROVING AGENT | Sanyo Chemical Industries, Ltd. (JP) | 2025-01-22 | — | — | EP | disclosed |
| WO-2024090537-A1 | ZINC POLYPHOSPHATE AND METHOD FOR PRODUCING SAME | カムイファーマ株式会社 | 2024-05-02 | — | — | WO | disclosed |
| WO-2023204274-A1 | MICROBIOTA IMPROVING AGENT | 三洋化成工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| CN-114539338-A | Disodium adenosine triphosphate trihydrate crystal and preparation method thereof | 苏州赜文医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114539338-A | Disodium adenosine triphosphate trihydrate crystal and preparation method thereof | 苏州赜文医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114539338-A | Disodium adenosine triphosphate trihydrate crystal and preparation method thereof | 苏州赜文医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-111411102-B | Preparation method of ZIF-8/enzyme composite material | 复旦大学 | 2022-02-15 | — | — | CN | disclosed |
| CN-111411102-A | Preparation method of ZIF-8/enzyme composite material | 复旦大学 | 2020-07-14 | — | — | CN | disclosed |
| EP-0973938-B1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS INC (US) | 2008-01-02 | — | — | EP | disclosed |
| EP-0973938-A4 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS INC (US) | 2000-04-26 | — | — | EP | disclosed |
| EP-0973938-A1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | Specialty Assays, Inc. (US) | 2000-01-26 | — | — | EP | disclosed |
| US-5801006-A | Use of NADPH and NADH analogs in the measurement of enzyme activities and metabolites | SPECIALTY ASSAYS, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| WO-1998033936-A1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS, INC. (US) | 1998-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268852-A1 | MICROBIOTA IMPROVING AGENT | TLR1, TLR4, TYR | ADRB2 2931/4885ADORA1 1314/4885PDE4D 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.